Geneticist's age-reversal tech for vision loss enters human trials

yuancheng lu, a geneticist at the whitehead institute, has been working on gene therapies to prevent age-related vision loss. in 2018, he used an age-reversal technique called reprogramming to repair the optic nerves of mice. the treatment, now called er-100, has entered human clinical trials for glaucoma. lu's work has generated significant interest, with investors like us tech billionaires and china's richest people meeting with him. the treatment aims to restore youthful state to cells and could potentially change humanity.